E-LIB Suche - Ergebnisse für: Luo, Donghan

1

Low Incidence and Brief Duration of Gastrointestinal Advers..:

Dunn, Keith ; Baugh, Bryan ; Bejou, Nika...
Journal of the International Association of Providers of AIDS Care (JIAPAC). 21 (2022) - p. 232595822210882 , 2022

Link: https://doi.org/10.1177/..

2

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in..:

Dunn, Keith ; Bushen, Jennifer ; Luo, Donghan...
HIV Medicine. 24 (2022) 3 - p. 279-289 , 2022

Link: https://doi.org/10.1111/..

3

Rapid initiation of darunavir/cobicistat/emtricitabine/teno..:

Dunn, Keith ; Rogers, Rachel ; Simonson, Richard Bruce...
HIV Research & Clinical Practice. 22 (2021) 2 - p. 55-61 , 2021

Link: https://doi.org/10.1080/..

4

Pooled resistance analyses of darunavir once-daily regimens..:

Lathouwers, Erkki ; Seyedkazemi, Sareh ; Luo, Donghan...
HIV Research & Clinical Practice. 21 (2020) 2-3 - p. 83-89 , 2020

Link: https://doi.org/10.1080/..

5

1015. Gastrointestinal (GI) Adverse Events With Darunavir/C..:

Dunn, Keith ; Huang, Yangxin ; Baugh, Bryan...
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S536-S537 , 2020

Link: https://doi.org/10.1093/..

6

Simeprevir, daclatasvir, and sofosbuvir for hepatitis C vir..:

Lawitz, Eric ; Poordad, Fred ; Gutierrez, Julio A....
Health Science Reports. 3 (2020) 2 - p. , 2020

Link: https://doi.org/10.1002/..

7

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in..:

Huhn, Gregory D ; Crofoot, Gordon ; Ramgopal, Moti...
Clinical Infectious Diseases. 71 (2019) 12 - p. 3110-3117 , 2019

Link: https://doi.org/10.1093/..

8

887. High Rates of Virologic Suppression Achieved in HIV-1–..:

Huhn, Gregory D ; Ramgopal, Moti ; Crofoot, Gordon...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S21-S21 , 2019

Link: https://doi.org/10.1093/..

9

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in..:

Huhn, Gregory D. ; Eron, Joseph J. ; Girard, Pierre-Marie...
AIDS Research and Therapy. 16 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

10

2509. Pooled Resistance Analyses of Darunavir (DRV) Once Da..:

Lathouwers, Erkki ; Seyedkazemi, Sareh ; Luo, Donghan...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S870-S871 , 2019

Link: https://doi.org/10.1093/..

11

541. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenami..:

Spinner, Christoph D ; Rashbaum, Bruce ; Mcdonald, Cheryl...
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S201-S201 , 2018

Link: https://doi.org/10.1093/..

12

Evaluation of Cardiovascular Disease Risk in HIV-1–Infected..:

Opsomer, Magda ; Dimitrova, Dessislava ; Verspeelt, Johan...
Drugs in R&D. 18 (2018) 3 - p. 199-210 , 2018

Link: https://doi.org/10.1007/..

13

Correction to: Evaluation of Cardiovascular Disease Risk in..:

Opsomer, Magda ; Dimitrova, Dessislava ; Verspeelt, Johan...
Drugs in R&D. 18 (2018) 3 - p. 249-250 , 2018

Link: https://doi.org/10.1007/..

14

Efficacy, safety and pharmacokinetics of simeprevir and TMC..:

Bourgeois, Stefan ; Van Vlierberghe, Hans ; Moreno, Christophe...
BMC Gastroenterology. 17 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

15

Patient-Reported Outcomes in Patients with Chronic Hepatiti..:

Chan, Eric ; Lawitz, Eric ; Kwo, Paul Yien...
Gastroenterology. 152 (2017) 5 - p. S1094-S1095 , 2017

Link: https://doi.org/10.1016/..